Addiction News and Research

RSS

C.A.R.E.S. Alliance launches online tools for addressing misuse and abuse of pain medications

The C.A.R.E.S. Alliance, a new patient safety organization, today launched a range of online tools designed to help solve the growing problem of misuse and abuse of opioids by identifying the risks associated with these powerful pain medications. The free resources offered through the C.A.R.E.S. (Collaborating & Acting Responsibly to Ensure Safety) Alliance promote safety in prescribing, dispensing, using, storing and disposing of these commonly abused pain medications.

9 Sep 2010

NIH announces $161.3 million for expansion of Pharmacogenomics Research Network

The National Institutes of Health plans to spend $161.3 million over the next five years to expand the Pharmacogenomics Research Network (PGRN), a nationwide collaborative of scientists focused on understanding how genes affect a person's response to medicines.

8 Sep 2010

Researchers discover tolerance mechanism in chronic morphine treatment

Researchers from Mount Sinai School of Medicine have discovered a major mechanism underlying the development of tolerance to chronic morphine treatment. The discovery may help researchers find new therapies to treat chronic pain, and reduce tolerance and side effects associated with morphine use. The findings are published in the July 20th issue of Science Signaling.

8 Sep 2010

NIH awards St. Jude $8.6M to focus on anticancer agent research in children

With its new expansion of the Pharmacogenomics Research Network (PGRN), the National Institutes of Health (NIH) awarded St. Jude Children's Research Hospital a prestigious grant to focus on anticancer agent research in children.

8 Sep 2010

Penn receives $12M NIH grant to study pharmacogenetics of nicotine addiction treatment

A variety of smoking cessation treatments are currently available for the more than 18 million adult Americans try to quit smoking each year, but success rates vary widely. Despite the importance of quitting smoking, more personalized approaches to smoking cessation treatment are needed to help smokers pick the right method that will work best for them. A major new personalized medicine clinical trial, led by addiction researchers at the University of Pennsylvania, will study how a smokers' genetic make-up influences their quitting success.

8 Sep 2010

UCSF scientists to receive two grants for personalized medicine research

UCSF scientists will receive two grants totaling $15.1 million over the next five years to expand their research into how genes affect an individual's response to medication and to strengthen a global network of researchers involved in these efforts.

7 Sep 2010

Methylphenidate facilitates recovery from drug addiction

A brain-scanning study at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory, conducted with collaborators from Stony Brook University, reveals that an oral dose of methylphenidate, commonly known as Ritalin, improves impaired brain function and enhances cognitive performance in people who are addicted to cocaine.

7 Sep 2010

New study may change the way clinicians make treatment decisions for patients who smoke

A study led by researchers in the Oregon Health & Science University Smoking Cessation Center may change the way clinicians make treatment decisions for their patients who smoke.

3 Sep 2010

American Cancer Society attacks electronic cigarettes while number of users increase

The American Cancer Society continues to attack electronic cigarettes and falsely label them as dangerous and ineffective, while the number of people using the products is increasing by 20,000 to 30,000 a week. Despite the ACS's claims, e cigarette reviews by consumers are still flooding in all over the Internet that smokers who are switching to e cigarettes and e liquid are breathing, tasting, and sleeping better than they ever did while smoking traditional cigarettes.

3 Sep 2010

Researcher awarded $1.8M grant to investigate sex differences in anxiety

Anxiety disorders afflict women twice as often as men, but estrogen might not be the reason. Testosterone, though, could be. That is one of the preliminary findings in the lab of Florida State University researcher Mohamed Kabbaj, associate professor in the College of Medicine. He recently was awarded a five-year, $1.8 million grant from the National Institute of Mental Health to investigate the sex differences in anxiety.

2 Sep 2010

Nabi Biopharmaceuticals, Diosynth sign long-term commercial manufacturing agreement

Nabi Biopharmaceuticals announced today that it has entered into a long-term commercial manufacturing agreement with Diosynth RTP, Inc. for the manufacture of Drug Substance integral to the production of NicVAX, Nabi's innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse.

2 Sep 2010

World becoming numb to HIV/AIDS: UNAIDS executive director

HIV infection is on the rise but there is potential to control the upsurge of infections with effective measures only if there are adequate funds. According to UNAIDS executive director Michel Sidibe the world has become numb to the fact that 7,400 people are being infected with AIDS every day and funds to combat it are not pouring in as they should. Since 2001, the number of newly infected people has fallen by 17 per cent a year - but there are still 2.7 million new cases each year.

1 Sep 2010

Canada hosts 13th World Congress On Pain

The Canadian Pain Society (CPS) eagerly welcomes leading pain experts from across Canada and around the globe to the 13th World Congress on Pain in Montreal, Quebec, from August 29 to September 2. Hosted by the International Association for the Study of Pain (IASP), more than 6,000 pain professionals will gather to share their thoughts, research and best treatment practices concerning this throbbing public health issue.

30 Aug 2010

Latest achievements in brain research and treatment for mental disorders

Mental disorders, such as depression, anxiety disorders, addiction and schizophrenia are the core challenge of most health care systems around the world. In the EU alone, each year 27% of the total adult population - this corresponds to 83 Million citizens - suffer from mental disorders. Depression alone affects almost 20 million ranking in the EU as the most disabling disorder of all diseases.

30 Aug 2010

CAMH welcomes Ontario's narcotics strategy to address inappropriate use of prescription opioids

The Government of Ontario's narcotics strategy will address the root causes of a significant and growing health problem - the inappropriate use of prescription opioids. The Centre for Addiction and Mental Health (CAMH) welcomes the strategy announced by The Honourable Deb Matthews, Minister of Health and Long-Term Care.

30 Aug 2010

CAMH to work on blueprint from Legislative Assembly's committee for mental health services

Legislative Assembly's committee on mental health and addictions has provided Ontario with a blueprint for improving care, says the province's largest mental health and addictions hospital.

30 Aug 2010

Study finds common risk factors linked with painkiller addiction

A new Geisinger study begins to unlock the puzzle of painkiller (opioid) addiction - why some people are more likely to become addicted than others. Geisinger investigators have found that patients with four common risk factors have a significantly higher risk of addiction. In addition, a history of severe drug dependence and drug abuse compounds the risk.

30 Aug 2010

American features series on HIV/AIDS: Prevention Strategies, MSM, Idus

A Scientific American series examines how recent scientific advances will guide future efforts to thwart HIV/AIDS and also looks at the epidemic among men who have sex with men (MSM) and injecting drug users (IDUs).

27 Aug 2010

Disulfiram drug effective in treating cocaine addiction: Research

Doctors have used the drug disulfiram to help patients stay sober for several decades. It interferes with the body's ability to metabolize alcohol, giving a fierce hangover to someone who consumes even a small amount of alcohol.More recently, disulfiram was shown to be effective in treating cocaine addiction as well, even though alcohol and cocaine affect the nervous system in different ways.

27 Aug 2010

Queen West Village Family Health Team to provide primary health care for community

Toronto's Queen West neighbourhood and the province's health care system alike will benefit from the August 24 announcement that a Family Health Team will be housed locally at the Centre for Addiction and Mental Health.

26 Aug 2010

Addiction News and Research

C.A.R.E.S. Alliance launches online tools for addressing misuse and abuse of pain medications

NIH announces $161.3 million for expansion of Pharmacogenomics Research Network

Researchers discover tolerance mechanism in chronic morphine treatment

NIH awards St. Jude $8.6M to focus on anticancer agent research in children

Penn receives $12M NIH grant to study pharmacogenetics of nicotine addiction treatment

UCSF scientists to receive two grants for personalized medicine research

Methylphenidate facilitates recovery from drug addiction

New study may change the way clinicians make treatment decisions for patients who smoke

American Cancer Society attacks electronic cigarettes while number of users increase

Researcher awarded $1.8M grant to investigate sex differences in anxiety

Nabi Biopharmaceuticals, Diosynth sign long-term commercial manufacturing agreement

World becoming numb to HIV/AIDS: UNAIDS executive director

Canada hosts 13th World Congress On Pain

Latest achievements in brain research and treatment for mental disorders

CAMH welcomes Ontario's narcotics strategy to address inappropriate use of prescription opioids

CAMH to work on blueprint from Legislative Assembly's committee for mental health services

Study finds common risk factors linked with painkiller addiction

American features series on HIV/AIDS: Prevention Strategies, MSM, Idus

Disulfiram drug effective in treating cocaine addiction: Research

Queen West Village Family Health Team to provide primary health care for community

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News